Published by ChinaMNC · Suzhou
China's Health-System Reforms: Compliance Pointers for Foreign Founders
A factual overview of China's health-sector priorities and regulatory evolution, with practical implications for foreign founders establishing or operating a business in China.
Why China's health reforms matter to foreign founders
China's leadership has placed public health at the center of national policy. For foreign founders, these priorities shape regulatory expectations, market opportunities, and compliance obligations in healthcare, insurance, pharmaceuticals, medical devices, and employer-provided benefits. Understanding the direction of reform helps you anticipate licensing requirements and plan operations.
Policy milestones you should know
The 2016 National Health Conference set a new health work guideline, shifting the focus from treating disease to protecting people's health. The subsequent “Healthy China 2030” plan outlined a roadmap. In 2019, the Basic Medical Health and Health Promotion Law was enacted as the first foundational law in this field. These steps signal a more structured and law-based approach to health governance.
Key takeaways for company registration and operation
- Legal framework: The 2019 law provides a foundation for health-related business activities, including standards for medical services and public health obligations.
- Preventive focus: Policies encourage reduced salt, oil, and sugar intake and regular exercise, which may affect food and beverage labeling, advertising, and workplace wellness programs.
- Public-health infrastructure: China has built large systems for medical services, traditional medicine, disease control, and medical insurance. Companies in these sectors should expect detailed licensing and quality rules.
Primary care and rural health
Reforms emphasize shifting medical resources downward to primary care and rural areas. For example, a township health center in Jiangsu now has modern equipment and regular visits from higher-level hospital doctors. The government supports telemedicine to balance resources, as noted during a 2020 inspection in Shaanxi. For foreign investors, this means opportunities in telemedicine, medical devices, and training, but also the need to comply with rules on internet healthcare and data security.
Medical insurance and drug procurement
Reforms include centralized volume-based procurement of drugs and medical consumables, adjustments to medical service pricing, and improved medical insurance payment methods. The share of out-of-pocket health spending has fallen to 27.1% of total health expenditure. The government aims for major illnesses to be treated within the province, general illnesses at city or county level, and common illnesses at primary care. Foreign companies involved in pharmaceuticals, devices, or insurance should monitor procurement rules and pricing policies.
Practical considerations for foreign founders
- Procurement participation: Centralized procurement may affect pricing and market access for drugs and devices. Understand eligibility and quality requirements.
- Insurance products: Commercial insurers should track changes in public insurance benefits and payment reforms, as these influence supplementary product design.
- Hospital management: The policy maintains public welfare in medical services and rejects full marketization, so foreign investment in hospitals faces specific restrictions and requires local guidance.
Health indicators and business implications
Official figures show improvements: in 2025, average life expectancy reached 79.25 years; infant mortality was 3.8 per 1,000; maternal mortality was 13.4 per 100,000; and the proportion of students with myopia fell to 49.9% in 2025, down 3.7 percentage points from 2018. The resident health literacy rate rose to 33.69%. These trends support demand for health products, preventive services, and workplace health programs, but claims must comply with advertising and food safety laws.
Workforce and compliance
The government calls for respect for medical workers and a supportive social atmosphere. Foreign companies employing medical professionals or operating clinics must follow licensing, labor, and qualification rules. The expansion of county-level medical communities and the goal that over 90% of residents can access nearby medical services within 15 minutes indicate continued investment in primary care. More than 4.22万个 village clinics and community health centers have traditional Chinese medicine facilities, and 80% of township health centers and community health service centers can provide appropriate TCM techniques. This may create partnership opportunities but also requires adherence to TCM regulations.
Action points for foreign founders
- Map licenses early: Identify whether your activity involves medical services, devices, drugs, health foods, or insurance, and obtain the required permits before registration.
- Monitor local pilots: Reforms are often tested locally (e.g., Sanming in Fujian) and then scaled. Track local health commissions' notices.
- Build compliance into products: Health claims, data handling, and telemedicine services face sector-specific rules. Budget for legal review.
- Engage local partners: For primary care and rural health projects, collaboration with local institutions may help navigate resource allocation and procurement.
Conclusion
China's health reforms create a more structured environment for healthcare-related businesses. Foreign founders should treat these policy directions as part of their regulatory due diligence, aligning market entry and operations with the legal framework and local implementation. This summary is based on information published by the relevant Chinese government website and is general information, not legal or tax advice.